PIRS Stock Analysis Overview
What this means: InvestorsObserver gives Pieris Pharmaceuticals Inc. (PIRS) an overall rank of 40, which is below average. Pieris Pharmaceuticals Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 40 means that 60% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
PIRS Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
PIRS Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
PIRS Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
PIRS Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
PIRS Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
PIRS Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
PIRS Stock Analysis Overview
What this means: InvestorsObserver gives Pieris Pharmaceuticals Inc. (PIRS) an overall rank of 40, which is below average. Pieris Pharmaceuticals Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 40 means that 60% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.